Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
06/2012
06/07/2012US20120142916 Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
06/07/2012US20120142752 Hiv protease inhibitors
06/07/2012US20120142698 Microbiocidal heterocycles
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142659 Compounds and their use as ikach blockers
06/07/2012US20120138877 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2459532A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process
06/06/2012EP2459531A2 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms
06/06/2012EP2459530A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
06/06/2012EP2459529A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
06/06/2012EP1685125B1 Pyrrole derivatives useful for the treatment of proliferative diseases
06/06/2012CN1997651B Oxidative degradation products of atorvastatin calcium
06/06/2012CN101830937B Visualized double-reaction tube fluorine-18 multifunctional automated synthesis module
06/06/2012CN101142182B Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors
06/05/2012US8193184 Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
06/05/2012US8193132 Lubricating oil additive and lubricating oil composition containing same
06/05/2012US8193131 Lubricating oil additive and lubricating oil composition containing same
06/05/2012US8193120 C2-phenyl-substituted cyclic ketonols
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2528667C Reagents for modifying biopharmaceuticals, the use and production thereof
06/05/2012CA2520740C Process for the preparation of amorphous calcium salt of atorvastatin
06/05/2012CA2520000C Compositions and methods for treating cancer
06/05/2012CA2324226C Inhibitors of caspases
05/2012
05/31/2012WO2012071293A2 Composition for improving oil recovery including n-lauroyl amino acid-based compounds and microbes
05/31/2012WO2012071291A2 Oil release with n-lauroyl amino acid-based compounds
05/31/2012WO2012070509A1 Method for producing nitrogen-containing heterocycle
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012069680A1 Method for synthesising intermediates of crambescidins and cimipronidine, and derivatives thereof
05/31/2012WO2012069275A1 Glycine derivatives and their use as muscarinic receptor antagonists
05/31/2012US20120135968 Tetracycline Compounds
05/31/2012US20120134977 Prodrugs containing albumin binding probe
05/31/2012US20120134934 Glycine derivatives and medicinal compositions thereof
05/31/2012US20120132564 Process for removing organic acids from crude oil and crude oil distillates
05/31/2012CA2820600A1 Glycine derivatives and their use as muscarinic receptor antagonists
05/31/2012CA2817378A1 Composition for improving oil recovery including n-lauroyl amino acid-based compounds and microbes
05/31/2012CA2817376A1 Oil release with n-lauroyl amino acid-based compounds
05/30/2012EP2457896A1 Tripeptides as caspase modulators
05/30/2012EP2457895A1 Tetrapeptide analogs
05/30/2012EP2456436A1 3-phenoxymethylpyrrolidine compounds
05/30/2012EP2137146B1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
05/30/2012EP2049478B1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
05/30/2012EP1771453B1 Hepatitis c inhibitor dipeptide analogs
05/30/2012EP1670787B1 Cytokine inhibitors
05/30/2012CN202237359U N-vinyl pyrrolidone crystalizing device
05/30/2012CN1774420B Process for the preparation of N-substituted 2-cyanopyrrolidines
05/30/2012CN102482213A Nmp distilling apparatus
05/30/2012CN102482212A Carboxamide compounds and their use as calpain inhibitors
05/30/2012CN102482203A 碳环glyt1受体拮抗剂 Carbocyclic glyt1 receptor antagonist
05/30/2012CN102477009A 取代的（s）-苯甲磺酰基吡咯烷-3-氨基衍生物及其制备方法与应用 Substituted (s) - phenylmethylsulfonyl pyrrolidin-3-amino derivatives, preparation method and application
05/30/2012CN101657418B Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
05/29/2012US8188301 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
05/29/2012US8188300 Atorvastatin calcium propylene glycol solvates
05/29/2012US8188296 Gentisic acid for stabilising 123-I radiopharmaceuticals
05/29/2012US8188145 Synthetic lactone formulations and method of use
05/29/2012US8188144 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
05/29/2012US8188140 Uses of ion channel modulating compounds
05/29/2012US8188138 Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
05/29/2012US8188122 Insecticidal aryl pyrrolidines
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2521425C Substituted phenoxy-acetic acids
05/29/2012CA2512752C Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/29/2012CA2458611C Aminobenzophenones as interleukin 1-beta and tumour necrosis factor-alpha inhibitors
05/24/2012WO2012065953A1 Substituted carbamoylcycloalkyl acetic acid derivatives as nep inhibitors
05/24/2012WO2010065833A3 Functionalized n-substituted pyrrolidonium ionic liquids
05/24/2012US20120130088 N-Substituted Pyrrolidonium Ionic Liquids with Expanded Linker
05/24/2012US20120130076 Synthetic Multimerizing Agents
05/24/2012US20120129909 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
05/24/2012US20120129883 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation ofthe serotonin 5-ht6 receptor
05/24/2012US20120129854 Pesticidal Arylpyrrolidines
05/24/2012US20120129833 Cyclic ketoenols for therapy
05/24/2012US20120129827 Novel derivatives of 1-alkyl-6-oxo-piperidine-3-carboxylic acids and 1-alkyl-5-oxo-pyrrolidine-3-carboxylic acids and their uses as cooling compounds
05/24/2012US20120129818 Compositions and Methods for Treatment of Cardiovascular Disease
05/24/2012US20120128592 Surface enhanced raman spectroscopy (sers) compounds and methods of their preparation
05/23/2012EP2455367A1 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/23/2012EP2454234A2 3-phenoxymethylpyrrolidine compounds
05/23/2012EP2454229A1 Amino acid derivatives for the treatment of neuropathic pain
05/23/2012CN102471259A 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
05/23/2012CN102471258A 3-苯氧基甲基吡咯烷化合物 3-phenoxy-methyl-pyrrolidine compounds
05/23/2012CN102469823A 用于咸味应用的调味成分 Flavoring ingredients for savory applications
05/23/2012CN102464612A 含哌嗪氨基甲酸酯的二卤丙烯醚类化合物与应用 Piperazine-containing urethane-dihalo ether compound of propylene and Applications
05/23/2012CN102093279B High-stability nonionic N-vinyl butyrate lactam iodine and preparation method thereof
05/23/2012CN101486674B Preparation of glimepiride raw material
05/22/2012US8183389 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound
05/22/2012US8183280 FAP inhibitors
05/22/2012US8183019 (3R,4R)-3-hydroxy-4-hydroxymethylpyrrolidine or (3S,4S)-3-hydroxy-4-hydroxymethylpyrrolidine; enzyme-catalysed enantioselective hydrolysis of a racemic 3,4-trans-disubstituted pyrrolidinone; for purine nucleoside phosphorylase (PNP) inhibitors
05/22/2012US8182581 use of these novel bis-cationic and/or bis-anionic ionic liquids as the stationary phase in a gas chromatographic column
05/22/2012CA2531064C Novel heteroaryl derivative
05/22/2012CA2479005C Amorphous atorvastatin calcium or pravastatin sodium hmg-coa reductase inhibitors of desired particle size
05/18/2012WO2012063207A1 Lactam derivatives useful as orexin receptor antagonists
05/18/2012WO2012062332A2 Novel photoinitiators
05/18/2012WO2012062036A1 Preparation method and applications of a two-ring intermediate including a penem-type side chain
05/18/2012WO2012061926A1 Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
05/18/2012WO2012012410A3 Kappa opioid receptor agonists
05/18/2012CA2815179A1 Lactam derivatives useful as orexin receptor antagonists
05/17/2012US20120123134 Manufacturing process for (S)-Pregabalin
05/17/2012US20120123133 Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins
05/17/2012US20120123132 Novel crystalline form of atorvastatin hemi-calcium salt, hydrate thereof, and method of producing the same
05/17/2012US20120122951 Skin-whitening agent and cosmetic method for whitening skin
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 404